AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2014
May 9, 2014
32566_dirs_2014-05-09_04d9f146-e439-4d0a-8181-2ff4caba67da.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2014-05-09
Reporting Person: Rogers Ronald S. (Exec VP Corp Communications)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-09 | Common Stock | M | 8520.0 | $25.12 | Acquired | 8520 | Direct |
| 2014-05-09 | Common Stock | S | 8520.0 | $36.01 | Disposed | 0 | Direct |
| 2014-05-09 | Common Stock | M | 3980.0 | $25.12 | Acquired | 3980 | Direct |
| 2014-05-09 | Common Stock | S | 3980.0 | $36.01 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-05-09 | Incentive Stock Option (right to buy) | $25.12 | M | 3980.0 | Disposed | 2021-04-01 | Common Stock (3980) | Direct |
| 2014-05-09 | Non-Qualified Stock Option (right to buy) | $25.12 | M | 8520.0 | Disposed | 2021-04-01 | Common Stock (8520) | Direct |
Footnotes
F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2